Tru St Partnership, L.P.'s Form 4 filing
Integra Lifesciences Holdings CorpIART · filed Mar 25, 2022
- Accession no.
- 0000899243-22-012345
- Filed
- Mar 25, 2022
- Trade date
- Dec 16, 2021-Mar 23, 2022
- Filing delay
- 99 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $19.5M. It was filed 99 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tru St Partnership, L.P.CIK 0001824663 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2021 | Common Stock | SSaleDisposed | −75,000 | $64.28F1 | −$4,821,000 | 8,740,930 | Direct | |
| Feb 9, 2022 | Common Stock | SSaleDisposed | −75,000 | $65.82F2 | −$4,936,500 | 8,665,930 | Direct | |
| Mar 23, 2022 | Common Stock | SSaleDisposed | −150,000 | $64.67F3 | −$9,700,500 | 8,515,930 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $64.28 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership.
Referenced by the price of 1 transaction in Table I.
- F2
The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $65.82 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership.
Referenced by the price of 1 transaction in Table I.
- F3
The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $64.67 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership.
Referenced by the price of 1 transaction in Table I.
Remarks
President, Chief Executive Officer and Chairman of the Board